Patents by Inventor Murali Krishna Bhavarisetti

Murali Krishna Bhavarisetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION OF DAPAGLIFLOZIN
    Publication number: 20190110994
    Abstract: Present invention discloses the stable pharmaceutical composition comprising premix of dapagliflozin with at least one pharmaceutically acceptable excipient(s) and process for preparation thereof. Dapagliflozin is highly hygroscopic and hence it is difficult to formulate dapagliflozin as stable pharmaceutical composition. Present invention discloses the stable pharmaceutical composition of dapagliflozin comprising premix of dapagliflozin with lactose.
    Type: Application
    Filed: March 30, 2017
    Publication date: April 18, 2019
    Applicant: LUPIN LIMITED
    Inventors: Chandrakant SHERVI, Byomakesh PANDA, Murali Krishna BHAVARISETTI, Subhasis DAS, Vijaya Kumar THOMMANDRU
  • Multilayered dosage form
    Patent number: 9622979
    Abstract: The present invention relates to a multilayered coated tablet comprising at least three layers, i.e., first, second and third layer wherein the first and third layers contain at least one active pharmaceutical ingredient and the second layer is either a placebo or an immediate-release drug layer. Further, the tablet has a delayed-release coating, wherein the coating may contain one or more pore-forming agents and/or orifices on one or both sides. Furthermore, it may contain an immediate-release layer of the drug over the delayed-release coating layer. The present invention further relates to processes for preparing such a multilayered coated tablet.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: April 18, 2017
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Murali Krishna Bhavarisetti, Kumaravel Vivek, Sreekanth Narravula, Romi Barat Singh
  • MULTILAYERED DOSAGE FORM
    Publication number: 20150132378
    Abstract: The present invention relates to a multilayered coated tablet comprising at least three layers, i.e., first, second and third layer wherein the first and third layers contain at least one active pharmaceutical ingredient and the second layer is either a placebo or an immediate-release drug layer. Further, the tablet has a delayed-release coating, wherein the coating may contain one or more pore-forming agents and/or orifices on one or both sides. Furthermore, it may contain an immediate-release layer of the drug over the delayed-release coating layer. The present invention further relates to processes for preparing such a multilayered coated tablet.
    Type: Application
    Filed: June 29, 2012
    Publication date: May 14, 2015
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Murali Krishna Bhavarisetti, Kumaravel Vivek, Sreekanth Narravula, Romi Barat Singh
  • MULTI-LAYERED, MULTIPLE UNIT PHARMACEUTICAL COMPOSITIONS
    Publication number: 20140112995
    Abstract: The present invention relates to pharmaceutical compositions comprising multilayered multiple units and processes for the preparation thereof.
    Type: Application
    Filed: December 23, 2013
    Publication date: April 24, 2014
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Murali Krishna BHAVARISETTI, Kanwarpreet Singh BAKSHI, Sreekanth NARRAVULA, Romi Barat SINGH, Ajay Kumar SINGLA
  • MODIFIED RELEASE LAMOTRIGINE TABLETS
    Publication number: 20110052686
    Abstract: The present invention relates to uncoated modified-release tablets of lamotrigine and the process for preparation thereof, wherein the tablets comprise a portion of lamotrigine in an admixture with a pH-dependent polymer.
    Type: Application
    Filed: September 2, 2010
    Publication date: March 3, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Murali Krishna Bhavarisetti, Rajan K. Verma, Romi Barat Singh
  • Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
    Publication number: 20100285119
    Abstract: Disclosed herein is an extended release pharmaceutical composition comprising at least two populations of extended release minitablets having a core comprising carbamazepine or its pharmaceutical salts, solvates, hydrates, an extended release polymer(s), wherein the extended release polymer of each population of minitablets is unalike. The process for manufacturing said composition is also disclosed.
    Type: Application
    Filed: January 12, 2009
    Publication date: November 11, 2010
    Applicant: Jubilant Organosys Ltd.
    Inventor: Murali Krishna Bhavarisetti